The Peptide Therapeutics Market is expected to exceed more than US$ 63 Billion by 2028 at a 9% CAGR 2023-2028.
Surging importance peptide therapeutics in the treatment of several diseases including cancer, nervous system disorders, ovarian cancer, breast cancer, and gastrointestinal cancers are fuelling product landscape. Increasing R&D investment by the major companies for improving efficacy owing to the absence of toxicity in the product portfolio. It is leading towards the development of excellent peptide therapeutic drugs is projected to boost industry growth.
Rising adoption of cost-effective measures by the physicians is accompanied by the risen healthcare expenditures from the several government authorities propelling product demand. Peptide consists of short amino acid monomer chains. However, production in large scale due to complexities peptide has become a major challenge for the biotech and pharmaceutical companies. New product developments such as multifunctional peptides through the hybrid technology are anticipated to drive market size.
Global peptide therapeutics market is segregated on the basis of applications as cancer, metabolic, CVD, respiratory, GIT, anti-infective, dermatology, CNS, and renal. Cancer is expected to witness notable gains in the forecast years. The report segments global peptide therapeutics market based on technology as liquid phase, solid phase, and hybrid phase.
Global peptide therapeutics market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional peptide therapeutics market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
Global peptide therapeutics market share consists of several players including Eli Lilly and Company, Merck & Co, CordenPharma International, AstraZeneca Plc, Ipsen S.A, PolyPeptide Group, Teva Pharmaceutical, Bachem AG, and Novo Nordisk A/S.
The Peptide Therapeutics Market has been segmented as below:
Peptide Therapeutics Market, By Application
Peptide Therapeutics Market, By Route of Administration
Peptide Therapeutics Market, By Type
Peptide Therapeutics Market, By Technology
Peptide Therapeutics Market, By Type of Molecule
Peptide Therapeutics Market, By API Peptide Type
Peptide Therapeutics Market, By Region
The report covers:
Report scope:
The global peptide therapeutics market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends.
The report scope includes market analysis on regional as well as country level. The report also provides competitive landscape covering company market shares with detailed profiling for major revenue contributing companies.
The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Company 1, Company 2, …Company N.
Reasons to Buy this Report:
Customization:
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Sutureless Aortic Valve Market
Tissue Processing Systems Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Driver 1
4.2.2. Driver 2
4.2.3. Driver 3
4.3. Restraints
4.3.1. Restraint 1
4.3.2. Restraint 2
4.4. Opportunities
4.4.1. Opportunity 1
4.4.2. Opportunity 2
4.5. Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
5. Peptide Therapeutics Market, By Application
5.1. Key Points
5.2. Cancer
5.3. Metabolic
5.4. CVD
5.5. Respiratory
5.6. GIT
5.7. Anti-infective
5.8. Dermatology
5.9. CNS
5.10. Renal
6. Peptide Therapeutics Market, By Route of Administration
6.1. Key Points
6.2. Parenteral
6.3. Oral
7. Peptide Therapeutics Market, By Type
7.1. Key Points
7.2. Innovative
7.3. Generic
8. Peptide Therapeutics Market, By Technology
8.1. Key Points
8.2. Liquid phase
8.3. Solid phase
8.4. Hybrid phase
9. Peptide Therapeutics Market, By Type of Molecule
9.1. Key Points
9.2. Vasopressin
9.3. Somatostatin
9.4. Calcitonin
9.5. Natriuretic
9.6. Immunopeptide
10. Peptide Therapeutics Market,By API Peptide Type
10.1. Key Points
10.2. In-house
10.3. CMO
11. Competitive Landscape
11.1. Introduction
11.2. Recent Developments
11.2.1. Mergers & Acquisitions
11.2.2. New Product Developments
11.2.3. Portfolio/Production Capacity Expansions
11.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
11.2.5. Others
12. Company Profile
12.1. Eli Lilly and Company
12.1.1. Company Overview
12.1.2. Product/Service Landscape
12.1.3. Financial Overview
12.1.4. Recent Developments
12.2. Merck & Co
12.2.1. Company Overview
12.2.2. Product/Service Landscape
12.2.3. Financial Overview
12.2.4. Recent Developments
12.3. CordenPharma International
12.3.1. Company Overview
12.3.2. Product/Service Landscape
12.3.3. Financial Overview
12.3.4. Recent Developments
12.4. AstraZeneca Plc
12.4.1. Company Overview
12.4.2. Product/Service Landscape
12.4.3. Financial Overview
12.4.4. Recent Developments
12.5. Ipsen S.A
12.5.1. Company Overview
12.5.2. Product/Service Landscape
12.5.3. Financial Overview
12.5.4. Recent Developments
12.6. PolyPeptide Group
12.6.1. Company Overview
12.6.2. Product/Service Landscape
12.6.3. Financial Overview
12.6.4. Recent Developments
12.7. Teva Pharmaceutical
12.7.1. Company Overview
12.7.2. Product/Service Landscape
12.7.3. Financial Overview
12.7.4. Recent Developments
12.8. Bachem AG
12.8.1. Company Overview
12.8.2. Product/Service Landscape
12.8.3. Financial Overview
12.8.4. Recent Developments
12.9. Novo Nordisk A/S.
12.9.1. Company Overview
12.9.2. Product/Service Landscape
12.9.3. Financial Overview
12.9.4. Recent Developments
The Peptide Therapeutics Market has been segmented as below:
Peptide Therapeutics Market, By Application
Peptide Therapeutics Market, By Route of Administration
Peptide Therapeutics Market, By Type
Peptide Therapeutics Market, By Technology
Peptide Therapeutics Market, By Type of Molecule
Peptide Therapeutics Market, By API Peptide Type
Peptide Therapeutics Market, By Region
SUBSCRIBE TO OUR NEWSLETTERS
